[1]
Chen, L., Zhou, N. and Zhang, L. 2024. Efficacy and Safety of Canagliflozin in STEMI Patients with Type 2 Diabetes after PCI: A Retrospective Study. The Heart Surgery Forum. 27, 8 (Aug. 2024), E898-E906. DOI:https://doi.org/10.59958/hsf.7627.